Aid by Sector
Unravelling the mechanisms of neurological damage during cryptococcal infection of the brain
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC ARL award, Cryptococcal meningitis kills more than 200,000 people each year in Sub-Saharan Africa and also causes neurological dysfunction and disability in survivors, most of which are of an economically productive age. Cryptococcal meningitis (CM) is the leading cause of HIV-associated meningitis, which is characterised by debilitating, inflammatory injury of the brain and a very high chance of death, even with treatment. In Sub-Saharan Africa, the number of people who die from CM and its complications is worsened by the unavailability and inaccessibility of safe and effective drugs. This research will fill the existing knowledge gap on how the brain is injured in cryptococcal meningitis. This models and methods would then serve as a platform for studying the mechanisms of other infections of the Central Nervous System that are caused by bacteria, parasites and viruses to inform the development of the much-needed new therapies in South Africa and the wider Sub-Saharan Africa region.
Improving access to asthma care for children and adolescents in Uganda
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC ARL award to understand whether innovations like checking every child and adolescent visiting primary care health facilities for asthma symptoms can lead to an increase in the number of children diagnosed with asthma, and whether education about asthma directed to patients and their caregivers can lead to improvements in the understanding of asthma, use of medicines and subsequent reduction in frequency of symptoms.
Ethiopia Crises 2 Resilience (EC2R)
UK - Foreign, Commonwealth Development Office (FCDO)
The Ethiopia Crises to Resilience (EC2R) programme is aimed to alleviate the impact of the conflict and drought to the poorest Ethiopians. The programme tries to address urgent humanitarian needs while maintaining the delivery of essential services across the country.
Tanzania Health Resilience Programme
UK - Foreign, Commonwealth Development Office (FCDO)
Drawing on the UK’s comparative advantage and priorities, and in line with Tanzania’s health sector strategy, the programme will: 1. Increase access, quality and equity of life-saving primary health care services by strengthening health systems that support ending preventable deaths of mothers, new-borns, and children (EPD). 2. Strengthen government ability to respond to health threats by supporting integrated disease surveillance systems at community level, and support preparedness systems and the initial response to disease outbreaks. 3. Support the increase and use of data to inform decision making and resource allocation to deliver equitable health outcomes. The programme will support Tanzania to regain momentum towards achieving Universal Health Coverage (UHC) by 2030 as measured by a change in Tanzania’s UHC index.
LAFIYA -UK Support for Health in Nigeria
UK - Foreign, Commonwealth Development Office (FCDO)
To save lives, reduce suffering and improve economic prospects for the poorest and most vulnerable in Nigeria through: i. Encouraging Government of Nigeria to increase resources invested in health (through advocacy, community accountability; and data to inform government prioritisation using a “delivery” approach, as used successfully in Pakistan) ii. Improving effectiveness and efficiency of public and private basic health services (through innovative financing mechanisms, strengthening health systems and working with private sector to deliver affordable health services for the poorest populations) iii. Reducing total fertility rate (through addressing social norms, demographic impact analysis, and support to family planning commodities and services).
Health Resilience Fund in Zimbabwe 2021-2025
UK - Foreign, Commonwealth Development Office (FCDO)
To support a resilient health system in Zimbabwe that is equipped to deliver quality sexual, reproductive, maternal, newborn, child and adolescent health and nutrition services.
I2I - Ideas to Impact - Testing new technologies and innovative approaches to address development challenges.
UK - Foreign, Commonwealth Development Office (FCDO)
I2I stimulates technological innovations addressing intractable development challenges, initially in the focal areas of energy, water and climate, and then increasingly in emerging “frontier” technologies with broader applicability. It tests different funding mechanisms and approaches - including prizes, peer-to-peer financing, Frontier Technology Livestreaming, and innovative cross-government partnerships - for ensuring technology ideas lead to a real-world development impact.
Investing in Human Capital through Partnerships Beyond Aid in the Social Sectors Programme
UK - Foreign, Commonwealth Development Office (FCDO)
To improve governance and accountability in education, health and social protection sectors and contribute to policy and research which will inform interventions to improve equity and reduce poverty.
The Evidence Fund - 300708
UK - Foreign, Commonwealth Development Office (FCDO)
The Evidence Fund procures and manages research and evaluations that primarily benefit ODA eligible countries. Most research and evaluations paid for by the Evidence Fund are country-specific, and all respond to requests for evidence to inform programme or policy decisions. Primarily serving research requests from HMG’s Embassies and High Commissions in ODA eligible countries, and from HMG policy and strategy teams, the Evidence Fund strengthens the evidence behind the UK’s priority international development investments and development diplomacy. The Evidence Fund also invests modest amounts of non-ODA, to strengthen the evidence behind wider UK foreign policy.
South Sudan Health Pooled Fund Phase III
UK - Foreign, Commonwealth Development Office (FCDO)
To provide a government led effective health system that will deliver improved access to quality health services across seven states in South Sudan with a specific focus on reducing maternal and child mortality. The Health Pooled Fund (HPF3) will reduce maternal and under-five mortality rates in South Sudan, through (i) the delivery of a basic package of health and nutrition services; (ii) promoting community engagement in health as a public good and (iii) supporting local health systems stabilisation.
Responding to the needs of Women and Children in Yemen 301140
UK - Foreign, Commonwealth Development Office (FCDO)
This programme will address the devastating impact the conflict in Yemen is having on women and children, particularly the most marginalised. It will provide access to life-saving integrated health, nutrition, water, sanitation and hygiene (WASH) and protection services. This approach responds directly to two key UK humanitarian aims in Yemen: preventing famine and ensuring respect for International Humanitarian Law.
Communication-centered Parent-mediated treatment for Autism Spectrum Disorder in South Asia (COMPASS).
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC JGHT 7 Full 2017 award - Communicationcentered Parentmediated treatment for Autism Spectrum Disorder in South Asia (COMPASS).
A Novel High Intensity Short Interval Dance Intervention for Non Communicable Disease(NCD) Prevention in Asian Indian Adolescent Girls-THANDAV
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC JGHT award to develop a novel intensity short Interval Dance Intervention for Non Communicable Disease(NCD) Prevention in Asian Indian Adolescent Girls-THANDAV
Fluconazole plus flucytosine vs fluconazole alone for cryptococcal antigen-positive patients identified through screening: A randomised trial
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC Joint Global Health Trial to determine Fluconazole plus flucytosine vs fluconazole alone for cryptococcal antigen-positive patients identified through screening: A randomised trial. The trial aims to compare the efficacy of an oral combination of fluconazole plus flucytosine with fluconazole alone (the current recommended treatment) in reducing all-cause mortality in advanced HIV patients in Tanzania and South Africa.
An International Collaboration to Implement and Evaluate at Scale the Active Prevention and Treatment of Maternal Sepsis (APT-Sepsis Programme)
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC Joint Global health Trial to carefully answer the question if the Active Prevention Treatment sepsis programme reduces mothers dying or having the most severe infections will involve a clinical trial. This will be done in Malawi and Uganda.
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC Joint Global Health Trial on how to best to intervene working with community health workers to improve the nutritional status of adolescent girls in South Africa
Two decades of expansion of primary health care in Latin America: a multi-country evaluation and forecasting study for health-related SDGs
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC HSRI award to systematically address all these issues for a comprehensive evaluation of the effectiveness of PHC on the broadest possible range of morbidity and mortality outcomes in Brazil, Colombia, Ecuador and Mexico (BCEM).
Learning health systems: fostering participatory learning and action to equip rural health workers as change agents for maternal and newborn care.
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC JHSRI l aim is to understand if and how a participatory learning and action (PLA) intervention can improve organisational learning culture amongst rural health workers (HWs) and experiences of person-centred maternal and newborn health (MNH) care amongst women in rural South Africa.
Regulating e-pharmacy: challenges and opportunities for access and quality of care in LMIC health systems
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC JHSRI to assess the performance of e-pharmacies in India and Kenya, analyse the systems that regulate them, and identify opportunities for improving medicine quality, safety and accessibility.
GMP manufacture and Phase I clinical trial of a thermostable single-dose rabies vaccine for pre-exposure prophylaxis for children in endemic areas
DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY
MRC BMC: DPFS Full July 2016 award - GMP manufacture and Phase I clinical trial of a thermostable singledose rabies vaccine for preexposure prophylaxis for children in endemic areas
Advanced filters
To search for Programmes in a specific time period, please enter the start and end dates.